WASHINGTON (Reuters) - The U.S. House of Representatives on Saturday passed legislation that would give the Food and Drug Administration more authority to regulate companies that compound sterile drugs and ship them across state lines. The bill, called the Drug Quality and Security Act, now goes to the Senate for a vote. House and Senate committees agreed on the legislation on Wednesday. ... via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment